A detailed history of Anchor Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Anchor Investment Management, LLC holds 86,189 shares of ABBV stock, worth $16.3 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
86,189
Previous 85,498 0.81%
Holding current value
$16.3 Million
Previous $15.6 Billion 5.05%
% of portfolio
1.52%
Previous 1.63%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 20, 2024

BUY
$154.79 - $180.76 $106,959 - $124,905
691 Added 0.81%
86,189 $14.8 Billion
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $448,934 - $511,518
-2,809 Reduced 3.18%
85,498 $15.6 Billion
Q4 2023

Jan 02, 2024

BUY
$137.6 - $154.97 $12.2 Million - $13.7 Million
88,307 New
88,307 $13.7 Billion
Q3 2023

Jan 02, 2024

BUY
$133.59 - $154.65 $8,148 - $9,433
61 Added 0.07%
83,647 $12.5 Billion
Q2 2023

Jan 02, 2024

BUY
$132.51 - $164.9 $480,083 - $597,432
3,623 Added 4.53%
83,586 $11.3 Billion
Q1 2023

Jan 02, 2024

BUY
$144.61 - $166.54 $192,186 - $221,331
1,329 Added 1.69%
79,963 $12.7 Billion
Q4 2022

Jan 02, 2024

SELL
$138.31 - $165.87 $1.34 Million - $1.6 Million
-9,673 Reduced 10.95%
78,634 $12.7 Billion
Q3 2022

Jan 02, 2024

SELL
$134.21 - $153.93 $1.32 Million - $1.52 Million
-9,854 Reduced 11.16%
78,453 $10.5 Billion
Q2 2022

Jan 02, 2024

BUY
$137.62 - $174.96 $108,306 - $137,693
787 Added 0.98%
81,464 $12.5 Billion
Q1 2022

Jan 02, 2024

BUY
$131.98 - $163.75 $552,336 - $685,293
4,185 Added 5.47%
80,677 $13.1 Billion
Q4 2021

Jan 02, 2024

SELL
$107.43 - $135.93 $114,520 - $144,901
-1,066 Reduced 1.37%
76,492 $10.4 Billion
Q3 2021

Jan 02, 2024

SELL
$106.4 - $120.78 $1.14 Million - $1.3 Million
-10,749 Reduced 12.17%
77,558 $8.37 Billion
Q2 2021

Jan 02, 2024

BUY
$105.21 - $117.21 $190,009 - $211,681
1,806 Added 2.43%
76,177 $8.58 Billion
Q1 2021

Jan 02, 2024

BUY
$102.3 - $112.62 $1.03 Million - $1.14 Million
10,100 Added 15.71%
74,371 $8.05 Billion
Q4 2020

Jan 02, 2024

BUY
$80.49 - $108.67 $878,226 - $1.19 Million
10,911 Added 20.45%
64,271 $6.89 Billion
Q3 2020

Jan 02, 2024

SELL
$85.91 - $100.83 $3 Million - $3.52 Million
-34,947 Reduced 39.57%
53,360 $4.67 Billion
Q2 2020

Jan 02, 2024

BUY
$73.37 - $98.18 $177,702 - $237,791
2,422 Added 5.21%
48,953 $4.81 Billion
Q1 2020

Jan 02, 2024

BUY
$64.5 - $97.79 $207,045 - $313,905
3,210 Added 7.41%
46,531 $3.55 Billion
Q4 2019

Jan 02, 2024

BUY
$72.13 - $90.25 $86,123 - $107,758
1,194 Added 2.83%
43,321 $3.84 Billion
Q3 2019

Jan 02, 2024

SELL
$62.98 - $75.72 $2.91 Million - $3.5 Million
-46,180 Reduced 52.29%
42,127 $3.19 Billion
Q2 2019

Jan 02, 2024

SELL
$65.7 - $83.98 $67,671 - $86,499
-1,030 Reduced 2.5%
40,173 $2.92 Billion
Q1 2019

Jan 02, 2024

SELL
$77.14 - $90.79 $413,856 - $487,088
-5,365 Reduced 11.52%
41,203 $3.32 Billion
Q4 2018

Jan 02, 2024

BUY
$77.85 - $96.01 $5,683 - $7,008
73 Added 0.16%
46,568 $4.29 Billion
Q3 2018

Jan 02, 2024

SELL
$88.91 - $98.84 $3.72 Million - $4.13 Million
-41,812 Reduced 47.35%
46,495 $4.4 Billion
Q2 2018

Jan 03, 2024

SELL
$89.78 - $106.23 $3.68 Million - $4.35 Million
-40,961 Reduced 46.38%
47,346 $4.39 Billion
Q1 2018

Jan 03, 2024

SELL
$92.01 - $123.21 $54,653 - $73,186
-594 Reduced 1.28%
45,707 $4.33 Billion
Q4 2017

Jan 03, 2024

SELL
$89.56 - $98.21 $62,602 - $68,648
-699 Reduced 1.49%
46,301 $4.48 Billion
Q3 2017

Jan 03, 2024

BUY
$69.85 - $89.22 $97,370 - $124,372
1,394 Added 3.06%
47,000 $4.18 Billion
Q2 2017

Jan 03, 2024

SELL
N/A
-42,701 Reduced 48.36%
45,606 $3.31 Billion
Q1 2017

Jan 03, 2024

BUY
N/A
308 Added 0.69%
44,821 $2.92 Billion
Q4 2016

Jan 03, 2024

SELL
N/A
-278 Reduced 0.62%
44,513 $2.79 Billion
Q3 2016

Jan 03, 2024

BUY
N/A
248 Added 0.56%
44,791 $2.82 Billion
Q2 2016

Jan 03, 2024

SELL
N/A
-43,764 Reduced 49.56%
44,543 $2.76 Billion
Q1 2016

Jan 03, 2024

SELL
N/A
-44,371
43,936 $2.51 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.